Use of fecal immunochemical testing in patients presenting in primary care with lower GI symptoms.
作者信息
Fraser Callum G
机构信息
Senior research fellow, Centre for Research into Cancer Prevention and Screening, University of Dundee, Ninewells Hospital and Medical School, Dundee, Scotland.
出版信息
CMAJ. 2020 Apr 6;192(14):E377. doi: 10.1503/cmaj.74717.
Abstract
摘要
相似文献
1
Use of fecal immunochemical testing in patients presenting in primary care with lower GI symptoms.粪便免疫化学检测在基层医疗中出现下消化道症状患者中的应用。
CMAJ. 2020 Apr 6;192(14):E377. doi: 10.1503/cmaj.74717.
2
FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS.粪便潜血：化学检测与免疫化学检测的比较
Arq Gastroenterol. 2018 Apr-Jun;55(2):128-132. doi: 10.1590/S0004-2803.201800000-22.
3
Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.粪便免疫化学检测用于在初级保健中对有下腹部症状的患者进行分流，以确定是否需要转诊疑似结直肠癌患者：一项系统评价和成本效益分析。
Health Technol Assess. 2017 May;21(33):1-234. doi: 10.3310/hta21330.
4
A quantitative immunochemical fecal occult blood test for colorectal neoplasia.一种用于结直肠肿瘤的定量免疫化学粪便潜血试验。
Ann Intern Med. 2007 Feb 20;146(4):244-55. doi: 10.7326/0003-4819-146-4-200702200-00003.
5
Improving the effectiveness of fecal occult blood testing in a primary care clinic by direct colonoscopy referral for positive tests.通过对粪便潜血检测呈阳性者直接转诊进行结肠镜检查来提高基层医疗诊所粪便潜血检测的有效性。
J Healthc Qual. 2010 Nov-Dec;32(6):62-9. doi: 10.1111/j.1945-1474.2009.00071.x.
6
Cost-effectiveness of colonoscopy in screening for colorectal cancer.结肠镜检查在结直肠癌筛查中的成本效益
Ann Intern Med. 2000 Oct 17;133(8):573-84. doi: 10.7326/0003-4819-133-8-200010170-00007.
7
Immunochemical fecal occult blood test is not suitable for diagnosis of hemorrhoids.免疫化学粪便潜血试验不适用于痔疮的诊断。
Am J Med. 1997 Jun;102(6):551-4. doi: 10.1016/s0002-9343(97)89437-5.
8
Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests.综合医疗诊所中的粪便潜血检测：基于愈创木脂法和基于免疫化学法检测的比较
Am J Med. 2003 Aug 1;115(2):111-4. doi: 10.1016/s0002-9343(03)00294-8.
9
Relationship between fecal sampling times and sensitivity and specificity of immunochemical fecal occult blood tests for colorectal cancer: a comparative study.粪便采样次数与免疫化学法粪便潜血试验对结直肠癌检测的敏感性和特异性之间的关系：一项比较研究。
Dis Colon Rectum. 1997 Jul;40(7):781-4. doi: 10.1007/BF02055432.
10
A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.无症状人群中免疫化学粪便潜血试验与全结肠镜检查的比较。
Gastroenterology. 2005 Aug;129(2):422-8. doi: 10.1016/j.gastro.2005.05.056.
引用本文的文献
1
Enhancing insights into Global Cancer Statistics 2022: implications for cancer control.深化对《2022年全球癌症统计数据》的理解：对癌症控制的启示
Sci China Life Sci. 2025 Jan;68(1):294-296. doi: 10.1007/s11427-024-2734-6. Epub 2024 Oct 18.
2
Negative predictive value of fecal immunochemical testing in significant bowel disease screening: a systematic review and meta-analysis.粪便免疫化学检测在重大肠道疾病筛查中的阴性预测值：一项系统评价与荟萃分析
Int J Surg. 2025 Jan 1;111(1):1182-1190. doi: 10.1097/JS9.0000000000001844.
本文引用的文献
1
The appropriate use of fecal immunochemical testing.粪便免疫化学检测的合理应用。
CMAJ. 2020 Jan 20;192(3):E68. doi: 10.1503/cmaj.190901.
2
A Call for a Reconsideration of the Use of Fecal Occult Blood Testing in Emergency Medicine.呼吁重新审视粪便潜血检测在急诊医学中的应用。
J Emerg Med. 2020 Jan;58(1):54-58. doi: 10.1016/j.jemermed.2019.09.026. Epub 2020 Jan 9.
3
Impact of introducing a faecal immunochemical test (FIT) for haemoglobin into primary care on the outcome of patients with new bowel symptoms: a prospective cohort study.在基层医疗中引入粪便血红蛋白免疫化学检测（FIT）对新发肠道症状患者结局的影响：一项前瞻性队列研究。
BMJ Open Gastroenterol. 2019 May 4;6(1):e000293. doi: 10.1136/bmjgast-2019-000293. eCollection 2019.
4
Faecal immunochemical tests for haemoglobin (FIT) in the assessment of patients with lower abdominal symptoms: current controversies.粪便血红蛋白免疫化学检测（FIT）在评估下腹部症状患者中的应用：当前争议
Gastroenterol Hepatol. 2019 Apr;42(4):263-270. doi: 10.1016/j.gastrohep.2018.09.007. Epub 2018 Nov 17.
5
Setting up a service for a faecal immunochemical test for haemoglobin (FIT): a review of considerations, challenges and constraints.建立粪便血红蛋白免疫化学检测（FIT）服务：考虑因素、挑战和限制的回顾。
J Clin Pathol. 2018 Dec;71(12):1041-1045. doi: 10.1136/jclinpath-2018-205047. Epub 2018 Oct 1.
6
Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance.粪便免疫化学检测（FIT）有助于排除在基层医疗中出现下腹部症状的患者患结直肠癌的可能性：为新的英国国家卫生与临床优化研究所（NICE）DG30诊断指南提供信息而进行的一项系统评价。
BMC Med. 2017 Oct 24;15(1):189. doi: 10.1186/s12916-017-0944-z.
7
Fecal occult blood testing as a diagnostic test in symptomatic patients is not useful: a retrospective chart review.粪便潜血试验作为症状患者的诊断试验是没有用的：一项回顾性图表回顾。
Can J Gastroenterol Hepatol. 2014 Sep;28(8):421-6. doi: 10.1155/2014/189652. Epub 2014 Jul 11.
8
A future for faecal haemoglobin measurements in the medical laboratory.粪便血红蛋白检测在医学实验室的未来。
Ann Clin Biochem. 2012 Nov;49(Pt 6):518-26. doi: 10.1258/acb.2012.012065. Epub 2012 Sep 4.
Zotero 插件